Aether Biomachines Raises $15M to Reindustrialize America with AI-Designed Proteins
Aether Biomachines, the company reindustrializing America by turning AI-designed proteins into real-world solutions, today announced an additional $15 million in funding led by Tribe Capital, with participation from new and existing investors including Natural Capital, Henkel Corporation, Resilience Reserve, Shrug Capital, 4DX Ventures, Unless Partners, and Radicle Impact. The round brings Aether’s total funding to $64 million.
Aether Biomachines Appoints Erik Scher, Ph.D., to Board of Directors
Aether Biomachines, a nanotechnology company building a future of abundance, today announced the appointment of True North Venture Partners’ Erik Scher, Ph.D., to its Board of Directors. A distinguished leader with over two decades of experience in the technology industry, Dr. Scher will provide guidance to Aether’s team as they develop AI-driven nanotechnology to unlock novel materials, therapeutics, commercial products, and environmental strategies.
Aether Biomachines and Allonnia Announce Partnership to Engineer Breakthrough Biological Solutions to Degrade PFAS and Other Harmful Environmental Toxins
Aether Biomachines, a nanotechnology company building a future of abundance, and Allonnia LLC, the bio-ingenuity company dedicated to extracting value where others see waste, today announced an exclusive partnership to design enzymes to sustainably remove harmful perfluoroalkyl and polyfluoroalkyl substances (PFAS) from the environment. The partnership leverages Aether and Allonnia’s existing technologies that are uniquely capable of degrading PFAS to drastically improve environmental health for millions of people across the world.
